Current Atherosclerosis Reports

, Volume 10, Issue 6, pp 503–509

Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults

  • William S. Harris
  • Penny M. Kris-Etherton
  • Kristina A. Harris
Article

DOI: 10.1007/s11883-008-0078-z

Cite this article as:
Harris, W.S., Kris-Etherton, P.M. & Harris, K.A. Curr Atheroscler Rep (2008) 10: 503. doi:10.1007/s11883-008-0078-z

Abstract

Numerous organizations and national health agencies have begun to recommend consumption of the long-chain omega-3 fatty acids (FAs) eicosapentaenoic acid and docosahexaenoic acid (EPA and DHA), respectively, in pill or fish form for general cardiovascular health. The purpose of this article is to present a rationale for an official target intake of 400 to 500 mg/d of EPA + DHA in the United States. Six epidemiologic studies reporting EPA + DHA intake and risk of coronary heart disease (CHD) death have been conducted in the United States, and five studies reported statistically significant inverse trends. Meta-analysis of these data showed a significant dose-response relationship between risk for CHD death and intake (P = 0.03), with relative risk reductions of 37% at an average EPA + DHA intake of 566 mg/d. Coincidentally, two servings per week of oily fish (the current American Heart Association recommendation) would provide 400 to 500 mg/d. We conclude, therefore, that an intake of 400 to 500 mg/d of EPA + DHA is achievable by diet alone and would be expected to significantly reduce risk for death from CHD in healthy adults.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Current Medicine Group LLC 2008

Authors and Affiliations

  • William S. Harris
    • 1
  • Penny M. Kris-Etherton
  • Kristina A. Harris
  1. 1.Metabolism and Nutrition Research CenterSanford Research/University of South DakotaSioux FallsUSA

Personalised recommendations